On 1 April 2019, the National Institute for Health and Care Excellence was 20 years old. This is an anniversary worth noting, if for no other reason than how remarkable it is for a National Health Service quango (quasi-autonomous non-governmental organisation) to be still standing two decades after its inception. There are more reasons for marking and celebrating the National Institute for Health and Care Excellence's 20-year run. In the intervening years, the Institute has done much to advance the health of the UK population. It has achieved an international reputation for robust and fair healthcare prioritisation that is widely viewed as setting the global standard. The National Institute for Health and Care Excellence built this reputation not only through the rigorous development and application of scientific methods to guide its work but also through its efforts to articulate the underpinning social and ethical values that provide its decisions with robust justification. The National Institute for Health and Care Excellence's reputation also rests on its commitment to transparency, accountability and inclusiveness in facilitating public and patient input in its deliberations.
From the start, the National Institute for Health and Care Excellence developed a distinctive approach to its work. The Institute took a robust view on the need to provide evidence for the value of healthcare interventions. In a publicly funded but cash-limited system, citizens (and politicians) needed to be assured that the National Health Service would only fund interventions that provided good value for money. Yet, the National Institute for Health and Care Excellence went beyond these generalities to specify how value for money would be assessed. The National Institute for Health and Care Excellence considered whether the opportunity costs of investing in new interventions could be justified by the health gains they could offer. A threshold was set -a range of £20,000 to £30,000 per additional quality-adjusted life-year -above which a new intervention would not normally be considered a 'good buy' for the National Health Service and rejected because its adoption would likely displace more health than it offered. As a way of publicly justifying its decision-making processes, the National Institute for Health and Care Excellence developed a statement of what it termed its 'Social Value Judgements' in 2005. 1 This document was updated in 2008, in response to the National Institute for Health and Care Excellence acquiring responsibilities for public health. Both editions focused on value for money as a foundational consideration for ensuring fairness to National Health Service patients in the context of limited resources. As a testimony to Social Value Judgements' importance, the document was cited in the first judicial review of a National Institute for Health and Care Excellence decision:
The key principle underlying NICE's approach to appraisals is that the NHS's limited resources should be targeted on those treatments which provide best value for money. The principle is to be found at paragraph 4 Against this backdrop, the current consultation document, 'The principles that guide the development of NICE guidance and standards' is puzzling. This short document is not just a revision of principles but implies a wholly different approach to the application of the social and ethical values thought to be relevant to the National Institute for Health and Care Excellence's work. It is pitched entirely on the procedural principles that govern how the National Institute for Health and Care Excellence works. While important, these are no substitute for the underlying substantive social and ethical values that the National Institute for Health and Care Excellence is committed to help secure. Table 1 The National Institute for Health and Care Excellence's rationale for this dramatic change is that all the values relevant to the National Institute for Health and Care Excellence are available in other documents. These documents include the National Institute for Health and Care Excellence Charter, its process and methods manuals, and legal and establishment materials -in total, many hundreds of pages whose content is, for the most part, highly technical. The National Institute for Health and Care Excellence's social and ethical values may be implicit in these documents, but they are by no means explicit, and they certainly require interpretation. The National Institute for Health and Care Excellence also claims, questionably, that its values are 'after almost 2 decades, well understood and accepted'. Considering the first question, the main casualties of this new approach are likely to be accountability, transparency, consistency, and public, political and professional understanding of the reasons for the National Institute for Health and Care Excellence's decisions. The move away from substantive ethical values towards procedural principles enables the detail of decision-making procedures and the content of recommendations to remain almost entirely unspecified. Patients who are being denied treatment on the basis of the National Institute for Health and While goals such as reducing health inequalities are embedded in National Health Service legislation, to be meaningful and actually addressed, they must be enacted in the day-to-day functioning of the National Institute for Health and Care Excellence and other health and care organisations. Furthermore, although the historical divide between health and social care is becoming more blurred, this should not lead to an assumption that challenges in both areas are similar. Rather, analysis of the challenges and opportunities in the two areas working in a more integrated fashion is required. The National Institute for Health and Care Excellence has been responsible for developing social care guidance since 2013 but, according to the proposed Social Value 
